PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
32956692-8	2021	A pilot screening of a natural product library via this established FP screening assay identified sanguinarine analogues as potential beta-catenin/LEF1 interaction inhibitors.	sanguinarine	98-110	catenin beta 1	Homo sapiens	134-146	
32956692-9	2021	GST pull-down and surface plasmon resonance (SPR) assay demonstrated that beta-catenin/LEF1 interaction is a potential anticancer target of sanguinarine in vitro.	sanguinarine	140-152	catenin beta 1	Homo sapiens	74-86	
32508048-0	2020	Sanguinarine suppresses migration and metastasis in colorectal carcinoma associated with the inversion of EMT through the Wnt/beta-catenin signaling.	sanguinarine	0-12	catenin beta 1	Homo sapiens	126-138	
20032392-5	2009	Combined treatment with sanguinarine and TRAIL effectively induced Bid cleavage and loss of mitochondrial membrane potential, leading to the activation of caspases, and cleavage of poly(ADP-ribose) polymerase and beta-catenin.	sanguinarine	24-36	catenin beta 1	Homo sapiens	213-225